Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.
Pradilla G, Ratcliff JJ, Hall AJ, Saville BR, Allen JW, Paulon G, McGlothlin A, Lewis RJ, Fitzgerald M, Caveney AF, Li XT, Bain M, Gomes J, Jankowitz B, Zenonos G, Molyneaux BJ, Davies J, Siddiqui A, Chicoine MR, Keyrouz SG, Grossberg JA, Shah MV, Singh R, Bohnstedt BN, Frankel M, Wright DW, Barrow DL; ENRICH trial investigators; ENRICH Trial Investigators. Pradilla G, et al. Among authors: shah mv. N Engl J Med. 2024 Apr 11;390(14):1277-1289. doi: 10.1056/NEJMoa2308440. N Engl J Med. 2024. PMID: 38598795 Clinical Trial.
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.
Badar T, Knutson K, Foran JM, Gangat N, Pavelko KD, Kaufmann SH, Litzow MR, Murthy HS, Cogen D, Ushman M, Arsana A, Al-Kali A, Alkhateeb HB, Tefferi A, Patnaik MM, Shah MV. Badar T, et al. Among authors: shah mv. Blood Adv. 2024 Nov 21:bloodadvances.2024014553. doi: 10.1182/bloodadvances.2024014553. Online ahead of print. Blood Adv. 2024. PMID: 39571168 No abstract available.
What have we learned about TP53-mutated acute myeloid leukemia?
Shahzad M, Amin MK, Daver NG, Shah MV, Hiwase D, Arber DA, Kharfan-Dabaja MA, Badar T. Shahzad M, et al. Among authors: shah mv. Blood Cancer J. 2024 Nov 19;14(1):202. doi: 10.1038/s41408-024-01186-5. Blood Cancer J. 2024. PMID: 39562552 Free PMC article. Review.
Nonprescribed Substance Use in the General Hospital: A Retrospective Study.
Dockery LM, Kast KA, Smith M, Stewart LS, Reese T, Wiese AD, Shah MV, Marcovitz DE. Dockery LM, et al. Among authors: shah mv. J Acad Consult Liaison Psychiatry. 2024 Oct 5:S2667-2960(24)00105-8. doi: 10.1016/j.jaclp.2024.09.006. Online ahead of print. J Acad Consult Liaison Psychiatry. 2024. PMID: 39370110
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Wang ES, Issa GC, Erba HP, Altman JK, Montesinos P, DeBotton S, Walter RB, Pettit K, Savona MR, Shah MV, Kremyanskaya M, Baer MR, Foran JM, Schiller G, Adès L, Heiblig M, Berthon C, Peterlin P, Rodríguez-Arbolí E, Salamero O, Patnaik MM, Papayannidis C, Grembecka J, Cierpicki T, Clegg B, Ray J, Linhares BM, Nie K, Mitra A, Ahsan JM, Tabachri M, Soifer HS, Corum D, Leoni M, Dale S, Fathi AT. Wang ES, et al. Among authors: shah mv. Lancet Oncol. 2024 Oct;25(10):1310-1324. doi: 10.1016/S1470-2045(24)00386-3. Lancet Oncol. 2024. PMID: 39362248 Clinical Trial.
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms.
Banks SA, Decker P, Flanagan EP, Zekeridou A, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Bach CR, Eckel-Passow JE, Tobin WO; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic. Banks SA, et al. Among authors: shah mv. Blood Cancer J. 2024 Sep 5;14(1):153. doi: 10.1038/s41408-024-01118-3. Blood Cancer J. 2024. PMID: 39237493 Free PMC article. No abstract available.
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
Katamesh B, Nanaa A, He R, Viswanatha D, Greipp PT, Bessonen K, Nguyen P, Jevremovic D, Yi CA, Foran J, Begna K, Gangat N, Mangaonkar A, Saliba AN, Patnaik MM, Hogan WJ, Litzow M, Tefferi A, Shah MV, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: shah mv. Ann Hematol. 2024 Oct;103(10):4333-4336. doi: 10.1007/s00277-024-05971-x. Epub 2024 Aug 28. Ann Hematol. 2024. PMID: 39196377 No abstract available.
Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide.
Baranwal A, Langer KJ, Kharfan-Dabaja MA, Ayala E, Foran J, Murthy H, Roy V, Iqbal M, Palmer J, Sproat LZ, Chhabra S, Khera N, Durani U, Hefazi M, Mangaonkar A, Shah MV, Litzow MR, Hogan WJ, Alkhateeb HB. Baranwal A, et al. Among authors: shah mv. Transplant Cell Ther. 2024 Aug 16:S2666-6367(24)00589-X. doi: 10.1016/j.jtct.2024.08.009. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39154913
243 results